MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SYRE has $763,953K in assets. $93,142K in debts. $97,185K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
897.06%
Quick Ratio
897.06%
Cash Ratio
114.12%
Debt to Asset Ratio
12.19%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock-Series ANon Voti...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
97,185 85,721 64,897 81,659
Marketable securities
644,282 670,812 421,301 444,921
Prepaid expenses and other current assets
22,486 21,248 18,406 12,252
Total current assets
763,953 777,781 504,604 538,832
Other non-current assets
-0 0 0
Total assets
763,953 777,781 504,604 538,832
Accounts payable-Nonrelated Party
5,692 8,904 7,457 3,712
Cvr liability
50,260 22,820 11,020 59,900
Accrued and other current liabilities
29,160 26,947 23,827 19,416
Related party accounts payable-Related Party
50 14 3,970 31
Total current liabilities
85,162 58,685 46,274 83,059
Non-current cvr liability
6,690 3,860 3,230 0
Other non-current liabilities
1,290 ---
Total liabilities
93,142 62,545 49,504 83,059
Preferred stock-Series ANon Voting Convertible Preferred Stock
146,425 146,425 146,425 146,425
Preferred stock-Series BNon Voting Convertible Preferred Stock
9,395 9,395 9,395 9,395
Preferred stock-Preferred Stock Excluding Series AAnd BNon Voting Convertible Preferred Stock
0 0 0 0
Common stock, 0.0001 par value 400,000,000 shares authorized as of march31, 2026 and december31, 2025 78,839,858 shares and 78,189,811 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively
15 15 13 13
Additional paid-in capital
1,712,383 1,686,167 1,363,581 1,353,408
Accumulated other comprehensive (loss) income
-767 869 791 454
Accumulated deficit
-1,196,640 -1,127,635 -1,065,105 -1,053,922
Total stockholders equity
670,811 715,236 455,100 455,773
Total liabilities, convertible preferred stock and stockholders equity
763,953 777,781 504,604 538,832
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$644,282K Cash and cashequivalents$97,185K Prepaid expenses andother current assets$22,486K Total current assets$763,953K Total assets$763,953K Total liabilities,convertible preferred stock...$763,953K Total stockholdersequity$670,811K Total liabilities$93,142K Accumulated deficit-$1,196,640K Accumulated othercomprehensive (loss) income-$767K Additional paid-in capital$1,712,383K Total currentliabilities$85,162K Non-current cvr liability$6,690K Other non-currentliabilities$1,290K Preferred stock-SeriesANon Voting...$146,425K Preferred stock-SeriesBNon Voting...$9,395K Common stock, 0.0001par value...$15K Cvr liability$50,260K Accrued and othercurrent liabilities$29,160K Accountspayable-Nonrelated Party$5,692K Related party accountspayable-Related Party$50K

Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics, Inc. (SYRE)